Global Hemostats Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

  • ID: 4412618
  • Report
  • Region: Global
  • 278 pages
  • Data Bridge Market Research Private Limited
1 of 4

FEATURED COMPANIES

  • 3-D Matrix, Ltd.,
  • B.Braun Melsungen
  • CryoLife, Inc.
  • Ethicon US LLC (U.S.)
  • HEMOTEC MEDICAL GMBH
  • Pfizer and C.R. Bard Inc.
  • MORE

In this report, global hemostats market is projected to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024.

Based on geography, the global hemostats market is segmented into 5 geographical regions, such as:

  • North America
  • South America
  • Europe
  • APAC
  • MEA
  • Rest Of the World

Global hemostats market competition by top players including:

Ethicon US LLC (U.S.) is dominating the hemostats market followed by Pfizer and C.R. Bard Inc., along with others such as

  • Baxter
  • Vascular Solutions, Inc.
  • B.Braun Melsungen
  • 3-D Matrix, Ltd.,
  • Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company)
  • Anika Therapeutics, Inc.
  • Arch Therapeutics Inc.
  • Biom’Up SAS
  • CryoLife, Inc.
  • Gamma Therapeutics, Inc.
  • Hemostasis, LLC
  • MedTrade Products Limited, I
  • ntegra LifeSciences Corporation
  • Medline Industries, Inc.
  • HEMOTEC MEDICAL GMBH
  • Stryker
  • CSL Behring
  • Mallinckrodt
  • Equimedical, B.V.

The global hemostats market is segmented on the basis of type, application, distribution channel, and end user.

The global hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats.

On the basis of application, the market is segmented into surgery and wound closure.

On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3-D Matrix, Ltd.,
  • B.Braun Melsungen
  • CryoLife, Inc.
  • Ethicon US LLC (U.S.)
  • HEMOTEC MEDICAL GMBH
  • Pfizer and C.R. Bard Inc.
  • MORE

1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Overview of Global Hemostats Market
1.4. Currency and Pricing
1.5. Limitation
1.6. Markets Covered

2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered for the Study
2.4. Currency and Pricing
2.5. Research Methodology
2.6. Primary Interviews with Key Opinion Leaders
2.7. Secondary Source
2.8. Assumptions

3. Market Overview
3.1. Drivers
3.1.1. Chronic Conditions and Aging Population Leading to Increase in Number of Surgical Procedures
3.1.2. Technological Advancements
3.1.3. Increasing Number of Minimally Invasive Surgeries
3.1.4. Improving Healthcare Infrastructure and Increasing Healthcare Spending
3.2. Restraints
3.2.1. Reluctance of Surgeons Towards New Products
3.2.2. Weak Reimbursement
3.3. Opportunities
3.3.1. Unmet Medical Needs
3.3.2. Emerging Market
3.4. Challenges
3.4.1. Development of Substitute Products
3.4.2. Limitations of Hemostatic Agents in Achieving Hemostasis

4. Premium Insights

5. Regulatory
5.1. Overview
5.2. Regulatory Procedure

6. Reimbursement
6.1. Overview
6.2. Reimbursement Scenario

7. Executive Summary

8. Global Hemostats Market, by Type
8.1. Overview
8.2. Thrombin Based Hemostats
8.3. Combination Agent Hemostats
8.4. Oxidized Regenerated Cellulose Based Hemostats
8.5. Gelatin Based Hemostats
8.6. Collagen Based Hemostats

9. Global Hemostats Market,By Application
9.1. Overview
9.2. Global Hemostats Market, by Application
9.3. Wound Closure
9.4. Surgical Hemostats

10. Global Hemostats Market, by Distribution Channel
10.1. Overview
10.1.1. Direct Tenders
10.1.2. Retail

11. Global Hemostats Market, by End User
11.1. Overview
11.2. Hospitals
11.3. Ambulatory Centers
11.4. Community Healthcare
11.5. Clinics

12. Global Hemostats Market, by Geography
12.1. Overview
12.2. North America
12.2.1. U.S.
12.2.2. Canada
12.2.3. Mexico
12.3. Europe
12.3.1. Germany
12.3.2. France
12.3.3. U.K.
12.3.4. Italy
12.3.5. Spain
12.3.6. Russia
12.3.7. Turkey
12.3.8. Belgium
12.3.9. Netherlands
12.3.10. Switzerland
12.3.11. Rest of Europe
12.4. Asia-Pacific (APAC)
12.4.1. Japan
12.4.2. China
12.4.3. South Korea
12.4.4. India
12.4.5. Australia
12.4.6. Singapore
12.4.7. Thailand
12.4.8. Malaysia
12.4.9. Indonesia
12.4.10. Philippines
12.4.11. Rest of APAC
12.5. South America
12.5.1. Brazil
12.5.2. Rest of South America
12.6. MEA
12.6.1. South Africa
12.6.2. Rest of MEA

13. Global Hemostats Market, Company Landscape
13.1. Company Share Analysis: Global
13.2. Company Share Analysis: North America
13.3. Company Share Analysis: Europe
13.4. Company Share Analysis: APAC

14. Company Profiles
14.1. Ethicon Us, LLC (Subsidiary of Johnson & Johnson Services, Inc)

14.1.1. Company Overview
14.1.2. Revenue Analysis
14.1.3. Product Portfolio
14.1.4. Recent Developments
14.2. Pfizer
14.2.1. Company Overview
14.2.2. Revenue Analysis
14.2.3. Product Portfolio
14.2.4. Recent Developments
14.3. C.R Bard
14.3.1. Company Overview
14.3.2. Revenue Analysis
14.3.3. Product Portfolio
14.3.4. Recent Developments
14.4. Baxter
14.4.1. Company Overview
14.4.2. Revenue Analysis
14.4.3. Product Portfolio
14.4.4. Recent Developments
14.5. Vascular Solutions, Inc (Acquired by Teleflex Incorporated)
14.5.1. Company Overview
14.5.2. Revenue Analysis
14.5.3. Product Portfolio
14.5.4. Recent Developments
14.6. B.Braun Melsungen Ag
14.6.1. Company Overview
14.6.2. Revenue Analysis
14.6.3. Product Portfolio
14.6.4. Recent Developments
14.7. 3-D Matrix Ltd
14.7.1. Company Overview
14.7.2. Revenue Analysis
14.7.3. Product Portfolio
14.7.4. Recent Developments
14.8. Resorba Medical Gmbh
14.8.1. Company Overview
14.8.2. Revenue Analysis
14.8.3. Product Portfolio
14.8.4. Recent Developments
14.9. Anika Therapeutics, Inc.
14.9.1. Company Overview
14.9.2. Revenue Analysis
14.9.3. Product Portfolio
14.9.4. Recent Developments
14.10. Biom’Up
14.10.1. Company Overview
14.10.2. Revenue Analysis
14.10.3. Product Portfolio
14.10.4. Recent Developments
14.11. Cryolife, Inc.
14.11.1. Company Overview
14.11.2. Revenue Analysis
14.11.3. Product Portfolio
14.11.4. Recent Developments
14.12. Equimedical
14.12.1. Company Overview
14.12.2. Revenue Analysis
14.12.3. Product Portfolio
14.12.4. Recent Developments
14.13. Hemostasis, LLC
14.13.1. Company Overview
14.13.2. Revenue Analysis
14.13.3. Product Portfolio
14.13.4. Recent Developments
14.14. Medtrade Products Limited
14.14.1. Company Overview
14.14.2. Revenue Analysis
14.14.3. Product Portfolio
14.14.4. Recent Developments
14.15. Stryker
14.15.1. Company Overview
14.15.2. Revenue Analysis
14.15.3. Product Portfolio
14.15.4. Recent Developments
14.16. Arch Therapeutics, Inc.
14.16.1. Company Overview
14.16.2. Revenue Analysis
14.16.3. Product Portfolio
14.16.4. Recent Developments
14.17. Integra Lifesciences Corporation
14.17.1. Company Overview
14.17.2. Revenue Analysis
14.17.3. Product Portfolio
14.17.4. Recent Developments
14.18. Altaylar Medical
14.18.1. Company Overview
14.18.2. Revenue Analysis
14.18.3. Product Portfolio
14.18.4. Recent Developments
14.19. Biocer Entwicklungs-Gmbh
14.19.1. Company Overview
14.19.2. Revenue Analysis
14.19.3. Product Portfolio
14.19.4. Recent Developments
14.20. SMI (Starch Medical)
14.20.1. Company Overview
14.20.2. Revenue Analysis
14.20.3. Product Portfolio
14.20.4. Recent Developments

15. Related Reports

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3-D Matrix, Ltd.,
  • Anika Therapeutics, Inc.
  • Arch Therapeutics Inc.
  • B.Braun Melsungen
  • Baxter
  • Biom’Up SAS
  • CryoLife, Inc.
  • CSL Behring
  • Equimedical, B.V.
  • Ethicon US LLC (U.S.)
  • Gamma Therapeutics, Inc.
  • Hemostasis, LLC
  • HEMOTEC MEDICAL GMBH
  • Mallinckrodt
  • Medline Industries, Inc.
  • MedTrade Products Limited, I
  • ntegra LifeSciences Corporation
  • Pfizer and C.R. Bard Inc.
  • Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company)
  • Stryker
  • Vascular Solutions, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll